Home LiteratureArticle Details
PMID: 4830223 Published · ppublish English Journal Article

Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

The Journal of clinical investigation ·Vol. 53 ·No. 6 ·1974-06-00 ·Pages 1578-87

Charlesworth JA, Williams DG, Sherington E, Lachmann PJ, Peters DK

Abstract

Metabolic studies using radioiodine-labeled third component of complement (C3) and the glycine-rich beta glycoprotein (GBG), a major component of the C3b-feedback pathway, were undertaken in normal subjects, in 22 patients with evidence of complement activation, and in 11 patients with various renal diseases without evidence of complement activation. In seven normal subjects GBG was found to be a rapidly metabolized protein with catabolic rates ranging from 1.7% to 2.2% of the plasma pool/h, synthesis rates from 0.14 to 0.21 mg/kg per h. and extravascular/intravascular distribution ratios from 0.81 to 1.31. In patients with reduced plasma C3, both increased C3 fractional catabolic rates and reduced C3 synthesis rates were observed, and in some patients there was evidence of increased extravascular distribution of the protein. GBG catabolism was usually increased when there was evidence of C3 activation, presumably reflecting activation of the C3b-feedback; but GBG turnover was normal or only slightly accelerated in some patients with accelerated C3 catabolism and profound hypocomplementemia, suggesting that reduced C3 synthesis had limited activation of the C3b-feedback.

MeSH Terms
Complement Inactivator Proteins Complement System Proteins/biosynthesis,isolation & purification Erythrocytes/metabolism Feedback Glycine/metabolism Glycoproteins/blood,metabolism Humans Immunologic Deficiency Syndromes/blood,metabolism Iodine Radioisotopes Kidney Diseases/metabolism Metabolic Clearance Rate Properdin/analysis Protein Binding
Chemicals
Complement Inactivator Proteins Glycoproteins Iodine Radioisotopes Properdin Complement System Proteins Glycine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Charlesworth J A
Williams D G
Sherington E
Lachmann P J
Peters D K
References (27)
27 references, click to expand
  1. Complement studies in membrano-proliferative glomerulonephritis.
    Clin Exp Immunol. 1972 Jul;11(3):311-20 PMID: 4625395
  2. A method of trace iodination of proteins for immunologic studies.
    Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PMID: 4160044
  3. Metabolism of the third component of complement (C3) in normal human subjects.
    Clin Sci Mol Med. 1974 Feb;46(2):223-9 PMID: 4817274
  4. Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome.
    Mayo Clin Proc. 1973 May;48(5):340-8 PMID: 4267356
  5. Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.
    J Clin Invest. 1973 Mar;52(3):634-44 PMID: 4630981
  6. The theory of tracer experiments with 131I-labelled plasma proteins.
    Phys Med Biol. 1957 Jul;2(1):36-53 PMID: 13484460
  7. Isolation and properties of a glycine-rich beta-glycoprotein of human serum.
    Biochim Biophys Acta. 1970 Dec 22;221(3):529-35 PMID: 5499437
  8. The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).
    Immunology. 1973 Feb;24(2):259-75 PMID: 4632688
  9. Distribution and metabolism of I131 labeled proteins in man.
    Fed Proc. 1957 Jul;16(2):suppl 13-8 PMID: 13461943
  10. Serum C'3 lytic system in patients with glomerulonephritis.
    Science. 1969 Apr 25;164(3878):436-7 PMID: 4180576
  11. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
    N Engl J Med. 1972 Oct 26;287(17):835-40 PMID: 4627271
  12. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    J Clin Invest. 1970 Nov;49(11):1975-85 PMID: 4097977
  13. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    J Clin Invest. 1967 Dec;46(12):2021-34 PMID: 6074005
  14. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
    Immunology. 1972 Jan;22(1):147-58 PMID: 4622449
  15. Metabolism of radio-labelled C3: effects of in vivo activation in rabbits.
    Clin Exp Immunol. 1974 Mar;16(3):445-52 PMID: 4468849
  16. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia.
    Lancet. 1973 Sep 8;2(7828):535-8 PMID: 4125297
  17. Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis).
    Medicine (Baltimore). 1970 May;49(3):207-26 PMID: 4910985
  18. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS.
    Anal Biochem. 1965 Feb;10:358-61 PMID: 14302464
  19. Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3.
    N Engl J Med. 1973 Mar 22;288(12):601-6 PMID: 4686987
  20. Analysis of disappearance time-curves after single injection of labelled proteins.
    Ciba Found Symp. 1972;9:113-30 PMID: 4573089
  21. The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.
    Immunochemistry. 1971 Jan;8(1):81-8 PMID: 4100767
  22. The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
    J Exp Med. 1973 Feb 1;137(2):424-37 PMID: 4734403
  23. C3 proactivator convertase and its mode of action.
    J Exp Med. 1972 Apr 1;135(4):1003-8 PMID: 4111773
  24. Decreased synthesis of the third component of complement (C3) in hypocomplementemic systemic lupus erythematosus.
    Clin Exp Immunol. 1972 May;11(1):21-9 PMID: 5038771
  25. Inactivator of the third component of complement as an inhibitor in the properdin pathway.
    Proc Natl Acad Sci U S A. 1972 Oct;69(10):2910-3 PMID: 4507613
  26. Glomerular deposition of properdin in acute and chronic glomerulonephritis with hypocomplementemia.
    J Clin Invest. 1971 Mar;50(3):642-9 PMID: 5545124
  27. Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis.
    Lancet. 1973 Mar 3;1(7801):447-9 PMID: 4120364
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1974-06-00
Pages
1578-87
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC302653
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]